Autopsy report · NCT04831255

ZILRETTA™ for Treatment of Idiopathic Adhesive Capsulitis

“Not able to find enough subjects”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 9 months after it had already started.
• Ran for about 4 years 2 months before it stopped.
• 39 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

University of Virginia

Sponsor type

University, hospital or other

Conditions

Adhesive Capsulitis; Frozen Shoulder; Adhesive Capsulitis of Shoulder

Interventions

triamcinolone acetonide extended-release injectable suspension

Participants

39

Sites

1

Countries

United States

Trials that died the same way

• Infliximab Top-down in Pediatric Crohn
  “Not enough study subjects” (80% match in meaning)
• Safety Study of Inhaled Saline in Acute Lung Injury
  “difficult getting subjects” (79% match in meaning)
• In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
  “Not able to recruit subjects” (75% match in meaning)
• Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes
  “Unable to recruit any subjects” (74% match in meaning)
• Cognitive Processing in Patients Surviving Delirium. Neuropsychological, EEG and Structural Brain Correlates.
  “Not enough subjects.” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.